163 related articles for article (PubMed ID: 23909730)
1. Perigestational dietary folic acid deficiency protects against medulloblastoma formation in a mouse model of nevoid basal cell carcinoma syndrome.
Been RA; Ross JA; Nagel CW; Hooten AJ; Langer EK; DeCoursin KJ; Marek CA; Janik CL; Linden MA; Reed RC; Schutten MM; Largaespada DA; Johnson KJ
Nutr Cancer; 2013; 65(6):857-65. PubMed ID: 23909730
[TBL] [Abstract][Full Text] [Related]
2. Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma.
Fujii M; Noguchi K; Urade M; Muraki Y; Moridera K; Kishimoto H; Hashimoto-Tamaoki T; Nakano Y
J Hum Genet; 2011 Apr; 56(4):277-83. PubMed ID: 21368767
[TBL] [Abstract][Full Text] [Related]
3. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
4. Multifocal desmoplastic medulloblastoma in an african-american child with nevoid basal cell carcinoma (gorlin) syndrome. Case report.
Smucker PS; Smith JL
J Neurosurg; 2006 Oct; 105(4 Suppl):315-20. PubMed ID: 17328283
[TBL] [Abstract][Full Text] [Related]
5. Myogenic tumors in nevoid Basal cell carcinoma syndrome.
Hettmer S; Teot LA; Kozakewich H; Werger AM; Davies KJ; Fletcher CD; Grier HE; Rodriguez-Galindo C; Wagers AJ
J Pediatr Hematol Oncol; 2015 Mar; 37(2):147-9. PubMed ID: 24517962
[TBL] [Abstract][Full Text] [Related]
6. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.
Sun LS; Li XF; Li TJ
J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968
[TBL] [Abstract][Full Text] [Related]
7. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
[TBL] [Abstract][Full Text] [Related]
8. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.
Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L
Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323
[TBL] [Abstract][Full Text] [Related]
9. The large intracellular loop of ptch1 mediates the non-canonical Hedgehog pathway through cyclin B1 in nevoid basal cell carcinoma syndrome.
Yu FY; Hong YY; Qu JF; Chen F; Li TJ
Int J Mol Med; 2014 Aug; 34(2):507-12. PubMed ID: 24840883
[TBL] [Abstract][Full Text] [Related]
10. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
[TBL] [Abstract][Full Text] [Related]
11. Ptc1 heterozygous knockout mice as a model of multi-organ tumorigenesis.
Pazzaglia S
Cancer Lett; 2006 Mar; 234(2):124-34. PubMed ID: 15925443
[TBL] [Abstract][Full Text] [Related]
12. Novel PTCH1 Mutation in a Young Child With Gorlin Syndrome and Medulloblastoma.
Gloude NJ; Yoon JM; Crawford JR
Pediatr Blood Cancer; 2016 Jun; 63(6):1128-9. PubMed ID: 26840755
[No Abstract] [Full Text] [Related]
13. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis.
Pan S; Dong Q; Sun LS; Li TJ
Clin Cancer Res; 2010 Jan; 16(2):442-50. PubMed ID: 20068110
[TBL] [Abstract][Full Text] [Related]
14. [Nevoid basal cell carcinoma syndrome with corpus callosum agenesis, PTCH1 mutation and absence of basal cell carcinoma].
Mazzuoccolo LD; Martínez MF; Muchnik C; Azurmendi PJ; Stengel F
Medicina (B Aires); 2014; 74(4):307-10. PubMed ID: 25188659
[TBL] [Abstract][Full Text] [Related]
15. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors.
Wendling DS; Lück C; von Schweinitz D; Kappler R
Int J Mol Med; 2008 Dec; 22(6):787-92. PubMed ID: 19020777
[TBL] [Abstract][Full Text] [Related]
16. SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.
Mangum R; Varga E; Boué DR; Capper D; Benesch M; Leonard J; Osorio DS; Pierson CR; Zumberge N; Sahm F; Schrimpf D; Pfister SM; Finlay JL
Childs Nerv Syst; 2016 Dec; 32(12):2439-2446. PubMed ID: 27444290
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma associated with novel PTCH mutation as primary manifestation of Gorlin syndrome.
Crawford JR; Rood BR; Rossi CT; Vezina G
Neurology; 2009 May; 72(18):1618. PubMed ID: 19414732
[No Abstract] [Full Text] [Related]
19. Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report.
Sasaki R; Miyashita T; Matsumoto N; Fujii K; Saito K; Ando T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):e41-6. PubMed ID: 20659694
[TBL] [Abstract][Full Text] [Related]
20. Prenatal manifestation in a family affected by nevoid basal cell carcinoma syndrome.
Le Brun Keris Y; Jouk PS; Saada-Sebag G; Roux JJ; Mattei B; Bagait L; Paoloni-Giacobino A; Grandchamp B; Soufir N; Lespinasse J
Eur J Med Genet; 2008; 51(5):472-8. PubMed ID: 18539553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
